NEW Zealand's Medsafe regulator has updated a previous "alert communication" relating to Artemisia Annua or Sweet wormwood extract marketed as Arthrem (PD 19 Feb), confirming further reports of liver toxicity.
NZ's Centre for Adverse Reactions Monitoring said it had received a total of 25 reports of liver issues associated with Arthrem effective 30 Sep 2018, 11 of which had been received following publication of the previous alert.
The cases reported indicate use of Arthrem soft gel capsules (Promisia), with two cases also reporting use of GO Arthri-Remedy 1-A-Day soft gel capsules, which were withdrawn after publication of the previous alert.
See medsafe.govt.nz.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Nov 18
